Literature DB >> 12716021

Influence of temocapril on cultured ventral spinal cord neurons.

Yasuo Iwasaki1, Yasumitsu Ichikawa, Osamu Igarash, Ken Ikeda, Masao Kinoshita.   

Abstract

Temocapril, a angiotensin-converting enzyme (ACE) inhibitor, was tested for neurotrophic activity in primary explant cultures of ventral spinal cord of fetal rats (VSCC). Temocapril had a remarkable effect on neurite outgrowth with a 4.2- to 5.1-fold increased over that of control VSCC at their effective concentrations. In temocapril-treated VSCC, choline acetyltransferase (ChAT) activity was also increased 2.4-3.2 times over that of control at 10(-9) and 10(-8) M, respectively. Our data suggest that temocapril is a candidate for neurotrophic factors on spinal motor neurons in vitro. A possible therapeutic role for temocapril in damaged motor neurons, such as in motor neuropathy and amyotrophic lateral sclerosis, remains to be defined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716021     DOI: 10.1023/a:1022857632764

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines.

Authors:  Y Arakawa; M Sendtner; H Thoenen
Journal:  J Neurosci       Date:  1990-11       Impact factor: 6.167

2.  TRH analogue, TA-0910 (3-methyl-(s)-5,6-dihydroorotyl-L-histidyl-L-prolinamide) enhances neurite outgrowth in rat embryo ventral spinal cord in vitro.

Authors:  Y Iwasaki; K Ikeda; T Shiojima; M Kinoshita
Journal:  J Neurol Sci       Date:  1992-10       Impact factor: 3.181

Review 3.  Effect of angiotensin converting enzyme inhibitors on quality of life in hypertensive patients. Pharmacodynamic basis.

Authors:  C Govantes; J Marín
Journal:  Fundam Clin Pharmacol       Date:  1996       Impact factor: 2.748

4.  Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide.

Authors:  S Dimmeler; V Rippmann; U Weiland; J Haendeler; A M Zeiher
Journal:  Circ Res       Date:  1997-12       Impact factor: 17.367

5.  Enalapril and captopril enhance antioxidant defenses in mouse tissues.

Authors:  E M de Cavanagh; C G Fraga; L Ferder; F Inserra
Journal:  Am J Physiol       Date:  1997-02

Review 6.  Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression.

Authors:  M J Strong
Journal:  Can J Neurol Sci       Date:  2001-11       Impact factor: 2.104

7.  Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical.

Authors:  S Suzuki; H Sato; H Shimada; N Takashima; M Arakawa
Journal:  Pharmacology       Date:  1993-07       Impact factor: 2.547

8.  Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats.

Authors:  J Díez; A Panizo; M Hernández; F Vega; I Sola; M A Fortuño; J Pardo
Journal:  Hypertension       Date:  1997-11       Impact factor: 10.190

Review 9.  Oxygen free radicals and antioxidants: a review.

Authors:  D A Barber; S R Harris
Journal:  Am Pharm       Date:  1994-09

10.  The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats.

Authors:  R Lucius; S Gallinat; P Rosenstiel; T Herdegen; J Sievers; T Unger
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

View more
  1 in total

1.  Aspirin use associated with amyotrophic lateral sclerosis: a total population-based case-control study.

Authors:  Ching-Piao Tsai; Feng-Cheng Lin; Johnny Kuang-Wu Lee; Charles Tzu-Chi Lee
Journal:  J Epidemiol       Date:  2014-12-27       Impact factor: 3.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.